VC Firms Need to “Build” Better Products for LPs & Founders: The Fund Is No Longer Enough - Part 1/2

For a long time, venture capital had a simple story.

• Founders built companies.

• GPs picked the best founders.

• LPs picked the best GPs.

Everyone knew their role.

• The founder was the builder.

• The GP was the investor.

• The LP was the allocator.

Clean. Elegant. Easy to explain.

But private markets are not that simple anymore. Something has changed quietly in the background. Not through one dramatic headline. Not through one market crash. But slowly: through longer holding periods, delayed exits, more complex portfolios, the rise of secondaries, and a renewed obsession with DPI. The LP job has become much more complicated. And I wonder if we, as GPs, are still serving LPs as if their job has not changed.

Most LPs are still described as “capital allocators.” That is true, but it feels incomplete. LPs are no longer only allocating to funds, managing vintage years, and deciding who deserves a re-up. They are managing a much more dynamic system: exposure, liquidity, concentration, duration, capital calls, distributions, co-investments, secondaries, strategic relationships, information rights, and access to future winners.

At some point, this starts to look less like passive allocation… and more like portfolio product management. Not product management in the narrow sense of building an app. I mean product management as a way of thinking. A great product manager designs around user needs. They understand constraints. They manage trade-offs. They build feedback loops. They think about timing, bottlenecks, priorities, and outcomes. Maybe private-market portfolios now require the same kind of thinking.

And this raises an uncomfortable question for us as GPs: Are we still offering LPs a fund when what they increasingly need is a product? Of course, the fund is still the core product. Without performance, nothing else matters. No amount of beautiful reporting, events, dashboards, or communication can compensate for a bad fund. But maybe the fund alone is no longer enough.

For years, the standard GP pitch was built around a familiar sequence:

Here is our thesis.
Here is our team.
Here is our track record.
Here are our portfolio companies.
Here is our access.
Here is our next fund.

All of that still matters. But maybe it is no longer the full conversation. Maybe the better conversation starts with the LP’s actual pain. What liquidity problem are we helping them solve? What exposure are we giving them that they cannot easily build elsewhere? What information advantage are we sharing? What kind of access are we creating? Are we helping them understand emerging categories earlier? Are we creating co-investment opportunities? Are we building secondaries pathways? Are we helping them manage concentration? Are we giving them better visibility into what they actually own?

These questions change the GP’s role. The GP is no longer only a fund manager trying to raise capital. The GP becomes a builder of LP products.

That may sound strange at first. But if you look closely, it is already happening. Some firms are building better LP portals. Some are creating structured co-investment programs. Some are offering portfolio intelligence. Some are building continuation vehicles and liquidity pathways. Some are helping LPs access secondaries. Some are turning annual meetings from reporting rituals into strategic learning experiences.

The direction is clear. The old model was: “Trust us. We will invest your capital.” The new model may become: “Partner with us. We will help you build a better private-market system.” That is a very different promise. Because LPs are not all buying the same thing. A family office, a sovereign entity, a pension fund, a corporate LP, an endowment, a fund of funds, and a high-net-worth investor may all invest in the same VC fund, but they do not all have the same job to be done. Some want long-term compounding. Some want exposure to innovation. Some want strategic intelligence. Some want access to co-investments. Some want regional development. Some want relationships. Some want liquidity. Some want learning.

And yet, many VC firms still package the LP experience in roughly the same way for everyone.

• Same fund.

• Same pitch deck.

• Same quarterly report.

• Same annual meeting.

• Same occasional update.

Maybe that was fine when venture felt simpler, exits were more predictable, and paper markups were enough to keep everyone excited. But the market has changed. Companies are staying private longer. Exit windows are less predictable. DPI matters more than paper markups. Secondaries are becoming a structural tool, not just an emergency exit. Co-investments are becoming more important. LPs are asking harder questions. And private markets are becoming a larger, more permanent part of institutional portfolios.

In that world, LPs do not only need access. They need architecture. They need to understand how all the pieces fit together: primary funds, emerging managers, established managers, co-investments, direct deals, secondaries, continuation vehicles, liquidity windows, regional exposure, sector exposure, time horizon, and cash flow planning.

This is where the product analogy becomes useful. A product manager does not just ask, “What feature should we build?” They ask, “What problem are we solving, for whom, and how does every part of the experience help solve it?” Maybe GPs need to ask the same question. What problem are we solving for LPs? Are we solving access? Liquidity? Exposure? Information asymmetry? Strategic relevance? Regional knowledge? Early access to category creation? The challenge of backing innovation without building a large internal venture team?

Once we understand the real LP problem, we can build around it. A VC fund can become more than a blind pool of capital. It can become a platform for access, learning, liquidity, co-investment, secondaries, market intelligence, and strategic relationships.

This does not mean every VC firm should become a giant asset manager. Actually, smaller and emerging VC firms may have an advantage here. They can be closer to their LPs. They can design more intentionally. They can build around a specific LP pain instead of copying the same institutional template everyone else uses.

A small fund can still build a differentiated LP product. It can say: we give you access to a specific geography, stage, network, secondaries strategy, founder segment, or information advantage. The product does not have to be complex. It has to be clear.

Maybe that is the real shift. In the past, many GPs tried to differentiate mainly through thesis. Now, maybe differentiation needs to include LP product design. Not just: “What do we invest in?” But also: “What do we help our LPs build?” Because LPs are building something too. They are building exposure to the future. They are building institutional knowledge. They are building relationships with innovation ecosystems. They are building optionality. They are building a portfolio that must survive cycles, liquidity shocks, valuation corrections, manager dispersion, and changing strategic priorities.

And from the LP’s perspective, maybe GPs are not just fund managers. We are products:

• Long-duration products.

• Illiquid products.

• Relationship-heavy products.

• Information products.

• Access products.

• Trust products.

And if your product has a ten-year lifecycle, you probably need to think deeply about the user experience. Not only during fundraising. But across the full life of the relationship.

The future of VC may not only be about better sourcing, better picking, and better founder support. It may also be about better LP design. Because the GP-LP relationship is no longer just a capital relationship. It is becoming a product relationship. A strategy relationship. A liquidity relationship. An information relationship. A long-term system-design relationship.

So maybe the question for LPs is no longer only: “Where should we allocate capital?” Maybe it is: “What are we actually building with this capital?” And maybe the question for GPs is no longer only: “How do we raise the next fund?” Maybe it is: “What product are we building for our LPs?”